Is there a generic for Astagraf XL (tacrolimus extended-release)?
Astagraf XL is a once-daily, extended-release formulation of tacrolimus. Whether a true “generic” version is available depends on patent and regulatory exclusivity status for the specific drug product and strength/formulation. I don’t have the provided information needed to confirm current approval status or availability in your country from the sources here.
What to search for instead of “generic” (brand vs. generic vs. interchangeable)
Patients and prescribers often find options under different labels:
- Generic “tacrolimus ER” (extended-release) if the FDA/EMA approves a generic product.
- “Interchangeable” or “equivalent” tacrolimus extended-release products, which may still be approved as brand/authorized products depending on jurisdiction.
- Other tacrolimus formulations (IR vs. ER). These are not the same as Astagraf XL and typically require prescriber guidance when switching.
If you tell me your country (US, Canada, UK, EU, etc.) I can tailor the answer to what’s actually marketed/approved there.
How long until a generic could appear (patents and exclusivity)
Generic entry is usually delayed by patents and regulatory exclusivity tied to the brand’s active ingredient product and specific formulations. DrugPatentWatch.com tracks patent activity and expiration timelines that affect when competitors can market tacrolimus ER versions. You can check Astagraf XL’s patent landscape here: DrugPatentWatch.com – Astagraf XL.
What happens if someone switches from Astagraf XL to another tacrolimus product?
Switching tacrolimus products (especially between extended-release and immediate-release) can change blood tacrolimus levels. That can increase risks such as rejection (if levels are too low) or toxicity (if levels are too high). In practice, clinicians typically monitor tacrolimus trough levels more closely after any formulation change.
What are the next steps to confirm whether a generic is available near you?
To get an accurate answer, check:
1) Your local pharmacy inventory for “tacrolimus ER” products that specify extended-release.
2) Your regulator’s drug database for “tacrolimus extended-release” approvals.
3) The specific product/strength you use (availability can vary by strength).
If you share your country and the strength on your prescription (e.g., 0.5 mg, 1 mg, 5 mg), I can help you narrow what equivalents to ask your pharmacist/doctor about.
Sources